Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» multiple sclerosis
multiple sclerosis
2013 Should Be Interesting for Multiple Sclerosis Drugs
The Motley Fool
Mon, 12/31/12 - 04:36 pm
multiple sclerosis
drugs
Teva Pharmaceuticals
Pfizer
Merck
Biogen
Bayer
Novartis
Overnight success proves elusive for oral MS drugs
Fierce Pharma
Tue, 11/20/12 - 01:25 pm
multiple sclerosis
MS
Novartis
Gilenya
Sanofi
Aubagio
5 Drug Hopefuls That Are Going to Change Your Life: Part 1
Motley Fool
Thu, 11/15/12 - 04:25 pm
BG-12
Biogen Idec
MS
multiple sclerosis
Teva Pharmaceuticals: Valuation Is Too Depressed On Worries About Copaxone
Seeking Alpha
Mon, 11/5/12 - 11:30 am
Teva
Copaxone
MS
multiple sclerosis
Sanofi draws fire over cost of MS drug Lemtrada
Reuters
Thu, 11/1/12 - 11:51 am
MS
multiple sclerosis
Sanofi
Lemtrada
New Developments In Lipids To Watch Closely
Seeking Alpha
Sun, 10/28/12 - 11:31 am
Lpath
Pfizer
iSONEP
Asonept
macular degeneration
multiple sclerosis
MS
Regeneron
Roche
Bayer
Sanofi
Valeant Pharmaceuticals
GSK
Biogen slips as FDA extends review of MS drug
Yahoo/AP
Sat, 10/20/12 - 10:29 am
Biogen
BG-12
MS
multiple sclerosis
Review of Biogen Idec's MS Drug Delayed
Minyanville
Thu, 10/18/12 - 11:44 am
MS
multiple sclerosis
Biogen Idec
FDA
BG-12
Sanofi Aims to Add Second-Generation Lemtrada to Pipeline
Bloomberg
Fri, 10/12/12 - 12:12 pm
Sanofi
Lemtrada
multiple sclerosis
MS
Genzyme
Genzyme presents second Phase III study of once-daily AUBAGIO
Yahoo/Fly on the Wall
Fri, 10/12/12 - 11:00 am
Genzyme
Aubagio
MS
multiple sclerosis
Teva to Test MS Pill Laquinimod in Combination Therapy
Bloomberg
Thu, 10/11/12 - 10:21 am
Teva
MS
laquinimod
multiple sclerosis
Copaxone
Teva's 2nd-gen Copaxone makes the grade
Fierce Pharma
Wed, 10/10/12 - 11:59 am
Teva
Copaxone
MS
multiple sclerosis
Questcor: Results Of Physician Survey Suggest Increased Sales For Acthar Gel
Seeking Alpha
Mon, 10/8/12 - 12:49 pm
Acthar
Questcor
MS
multiple sclerosis
Acorda sinks after insurance provider questions MS drug
Yahoo/Fly on the Wall
Mon, 10/8/12 - 12:13 pm
Acorda
MS
multiple sclerosis
AMPYRA
XenoPort's CEO Hosts XenoPort XP23829 Clinical Trial Results Call (Transcript)
Seeking Alpha
Sat, 10/6/12 - 11:36 am
XenoPort
XP23829
multiple sclerosis
psoriasis
Battle Lines Drawn in the MS Market
Motley Fool
Wed, 09/26/12 - 10:56 am
multiple sclerosis
MS
BiogenIdec
BG-12
Sanofi
Aubagio
Gilenya
Novartis
Multiple sclerosis drugs seen gaining traction
Marketwatch
Fri, 09/21/12 - 11:32 am
MS
multiple sclerosis
BiogenIdec
BG-12
Aubagio
Sanofi
Questcor rises analyst sees greater Acthar sales
Yahoo/AP
Tue, 09/18/12 - 04:45 pm
Questcor
Acthar
infantile spasms
Medicaid
MS
multiple sclerosis
Aubagio approval sets Sanofi up with possible blockbuster
Fierce Pharma
Thu, 09/13/12 - 10:22 am
Aubagio
MS
multiple sclerosis
Genzyme
Sanofi
FDA Approves Genzyme’s AUBAGIO® (teriflunomide), a Once-Daily, Oral Treatment for Relapsing Multiple Sclerosis
Yahoo
Wed, 09/12/12 - 10:35 pm
FDA
Genzyme
Sanofi
Aubagio
MS
multiple sclerosis
Pages
« first
‹ previous
…
20
21
22
23
24
25
26
27
28
…
next ›
last »